Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
TNF Pharmaceuticals is a clinical-stage biotech focused on extending healthy lifespan through developing therapies targeting autoimmune and age-related diseases. Its key platforms include Isomyosamine, an oral immunometabolic drug for autoimmune conditions and frailty, and Supera-CBD, a synthetic analog of CBD for neurological and pain disorders. The company advances innovative, well-defined drug candidates with potential safety advantages, aiming for regulatory approval and strategic commercialization.
This description was generated via AI from an annual report. Updated about 1 year ago.